Quetiapine in the successful combination treatment of an assaultive patient with treatment-resistant schizoaffective disorder

Behavioral Medicine

Volumn 33, Issue 1, 2007, Pages 11-16

  Post, David Edward ^a  

^a Capital Area Human Services District   (United States)

Author keywords

Adverse effects; Atypical antipsychotic; Neuroleptic malignant syndrome; Quetiapine; Schizoaffective disorder

Indexed keywords

AMFEBUTAMONE; BENZATROPINE; CHLORPROMAZINE; CLONAZEPAM; FLUPHENAZINE; GABAPENTIN; HALOPERIDOL; LITHIUM; MESORIDAZINE; OLANZAPINE; PROPRANOLOL; QUETIAPINE; RISPERIDONE; THIAMINE; VALPROIC ACID;

ADULT; AGGRESSION; ANAMNESIS; ARTICLE; ASSAULT; BODY TEMPERATURE; CASE REPORT; CONFUSION; DRUG DOSE TITRATION; DRUG TOLERABILITY; DRUG WITHDRAWAL; HOSTILITY; HUMAN; LETHARGY; MALE; MENTAL DISEASE; NEUROLEPTIC MALIGNANT SYNDROME; PSYCHOSIS; PULSE RATE; SCHIZOAFFECTIVE PSYCHOSIS; SIDE EFFECT; TREATMENT INDICATION; UNSTEADINESS; URINE INCONTINENCE;

EID: 34249061400     PISSN: 08964289     EISSN: None     Source Type: Journal    
DOI: 10.3200/BMED.33.1.11-16     Document Type: Article

References (12)

1. McElroy SL, Keck PE Jr, Strakowski SM. An overview of the treatment of schizoaffective disorder. J Clin Psychiatry. 1999;60:16-22.
2. Glick ID, Murray SR, Vasudevan P, Marder SR, Hu RJ. (2001). Treatment with atypical antipsychotics: New indications and new populations. J Psychiatr Res. 2001;35:187-191.
3. Grieger TA, Benedek DM, Flynn J. Pharmacologic treatment of patients hospitalized with the diagnosis of schizoaffective disorder. J Clin Psychiatry. 2001;62:59-60.
4. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders: DSM-IV, 4th ed. Washington, DC: APA;1994.
5. Sajatovic M, Brescan DW, Perez et al. Quetiapine alone and added to a mood stabilizer for serious mood disorders. J Clin Psychiatry. 2001;62:728-732.
6. Susman VL. Clinical management of neuroleptic malignant syndrome. Psychiatr Q. 2001;72:325-336.
7. Arvanitis LA, Miller BG. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group. Biol Psychiatry. 1997;42:233-246.
8. Borison RL, Arvanitis LA, Miller BG. ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. US SEROQUEL Study Group. J Clin Psychopharmacol. 1996;16: 158-169.
9. Meats P. Quetiapine ('Seroquel'): an effective and well-tolerated atypical antipsychotic. Int J Psych Clin Pract. 1997;1:231-239.
10. Dev V, Raniwalla J. Quetiapine: a review of its safety in the management of schizophrenia. Drug Saf. 2000;23:295-307.
11. Goldstein JM. "Seroquel" (quetiapine fumarate) reduces hostility and aggression in patients with acute schizophrenia. Paper presented at: American Psychiatric Association 151st Annual Meeting; May 30-June 4, 1998; Toronto, Canada.
12. Brooks JO III. Successful outcome using quetiapine in a case of treatment-resistant schizophrenia with assaultive behavior. Schizophr Res. 2001;50:133-134.